{'52WeekChange': -0.44119084,
 'SandP52WeekChange': 0.0644362,
 'address1': 'One Rockefeller Plaza',
 'address2': '11th Floor',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.2,
 'askSize': 3200,
 'averageDailyVolume10Day': 8950350,
 'averageVolume': 4432085,
 'averageVolume10days': 8950350,
 'beta': 1.166386,
 'beta3Year': None,
 'bid': 1.19,
 'bidSize': 1400,
 'bookValue': None,
 'category': None,
 'circulatingSupply': None,
 'city': 'New York',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.32,
 'dayLow': 1.13,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': 2873.385,
 'enterpriseValue': 25860464,
 'exDividendDate': 326937600,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 0.8782857,
 'fiftyTwoWeekHigh': 2.74,
 'fiftyTwoWeekLow': 0.48,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 26952123,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 3,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.05641,
 'heldPercentInstitutions': 0.17454,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1572220800,
 'lastSplitFactor': '1113:1000',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/aikidopharma.com',
 'longBusinessSummary': 'Spherix Incorporated, a biotechnology company, '
                        'focuses on developing small-molecule anti-cancer '
                        'therapeutics. Its pipeline of therapeutics includes '
                        'therapies for pancreatic cancer, acute myeloid '
                        'leukemia, and acute lymphoblastic leukemia. The '
                        "company's platform consists of patented technology "
                        'from leading universities and researchers and in the '
                        'process of developing an innovative therapeutic drug '
                        'platform through partnerships with world renowned '
                        'educational institutions, including The University of '
                        'Texas at Austin and Wake Forest University. It has a '
                        'scientific research agreement with The University of '
                        'Texas Southwestern Medical Center to use machine '
                        'learning to find genetic markers in people that '
                        'indicate an increased risk of developing pancreatic '
                        'cancer. Spherix Incorporated was founded in 1967 and '
                        'is based in New York, New York.',
 'longName': 'AIkido Pharma Inc.',
 'market': 'us_market',
 'marketCap': 42253444,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_255115',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -11367000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.25,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '703 992 9325',
 'previousClose': 1.22,
 'priceHint': 4,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 4694.827,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.32,
 'regularMarketDayLow': 1.13,
 'regularMarketOpen': 1.25,
 'regularMarketPreviousClose': 1.22,
 'regularMarketPrice': 1.25,
 'regularMarketVolume': 7076592,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 34920200,
 'sharesPercentSharesOut': 0.0033000002,
 'sharesShort': 113865,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 41929,
 'shortName': 'AIkido Pharma Inc.',
 'shortPercentOfFloat': 0.0034999999,
 'shortRatio': 0.02,
 'startDate': None,
 'state': 'NY',
 'strikePrice': None,
 'symbol': 'AIKI',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 0.8262264,
 'volume': 7076592,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://aikidopharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '10020'}